Paper2209342
Biguanides and sulfonylureas as combination therapy in NIDDM.
Hermann LS. Diabetes Care, 1990. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Biguanides and sulfonylureas as combination therapy in NIDDM. Papers, record 2209342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2209342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biguanides | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Lipid Metabolism | Major topic |
| Sulfonylurea Compounds | Major topic |
| Adult | |
| Aged | |
| Drug Therapy, Combination | |
| Humans | |
| Middle Aged |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37581618 | Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice. | Diabetologia | 2023 | https://conductscience.org/library/papers/37581618 | PubMed |
| 36619226 | A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/36619226 | PubMed |
| 36617249 | Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. | J Clin Endocrinol Metab | 2023 | https://conductscience.org/library/papers/36617249 | PubMed |
| 36085061 | Hypertension attenuates the link of osteoprotegerin to reduced baroreflex sensitivity in type 2 diabetes mellitus patients on oral antidiabetic and antihypertensive therapy - a cross sectional study. | BMC Endocr Disord | 2022 | https://conductscience.org/library/papers/36085061 | PubMed |
| 32269463 | A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad. | Ethn Dis | 2020 | https://conductscience.org/library/papers/32269463 | PubMed |
| 27002150 | Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27002150 | PubMed |
| 25060887 | Metformin pharmacogenomics: current status and future directions. | Diabetes | 2014 | https://conductscience.org/library/papers/25060887 | PubMed |
| 11560289 | Modern pharmacotherapies for type 2 diabetes mellitus. | J Natl Med Assoc | 2001 | https://conductscience.org/library/papers/11560289 | PubMed |
| 10392666 | A risk-benefit assessment of metformin in type 2 diabetes mellitus. | Drug Saf | 1999 | https://conductscience.org/library/papers/10392666 | PubMed |
| 9972673 | Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable? | J Endocrinol Invest | 1998 | https://conductscience.org/library/papers/9972673 | PubMed |
| 9506242 | Oral antidiabetic agents. A guide to selection. | Drugs | 1998 | https://conductscience.org/library/papers/9506242 | PubMed |
| 9279500 | Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. | Drugs | 1997 | https://conductscience.org/library/papers/9279500 | PubMed |
| 8972242 | Oral antidiabetic drug use in the elderly. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8972242 | PubMed |
| 8435549 | Treating non-insulin-dependent diabetes. Oral agents or insulin? | Can Fam Physician | 1993 | https://conductscience.org/library/papers/8435549 | PubMed |
| 8075474 | Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review. | Drugs Aging | 1994 | https://conductscience.org/library/papers/8075474 | PubMed |
| 7848543 | Comparative tolerability profiles of oral antidiabetic agents. | Drug Saf | 1994 | https://conductscience.org/library/papers/7848543 | PubMed |
| 7601013 | Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. | Drugs | 1995 | https://conductscience.org/library/papers/7601013 | PubMed |
| 1742694 | Non-insulin-dependent (type II) diabetes mellitus. | CMAJ | 1991 | https://conductscience.org/library/papers/1742694 | PubMed |
| 1521215 | Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board. | CMAJ | 1992 | https://conductscience.org/library/papers/1521215 | PubMed |
| 1280575 | Management of non-insulin-dependent diabetes mellitus. | Drugs | 1992 | https://conductscience.org/library/papers/1280575 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2209342
GET https://conductscience.org/api/papers/v1/2209342/authors